NCT02736877

Brief Summary

The investigators will evaluate 30 patients with surgical indication for corneal transplantation. Participants will be divided according to the following diseases diseases: keratoconus, bullous keratopathy, corneal dystrophies. Participants will be informed about the risks and benefits of the study and sign an informed consent form. In the preoperative evaluation will be submitted to a complete ophthalmologic examination with complementary tests, such as optical coherence tomography. One group of participants will undergo corneal surgery using the OCT Lumera microscope RESCAN - ZEISS and another group with a conventional microscope. Everyone will have their filmed and documented surgery. The team of surgeons will answer the questionnaire on the surgical difficulty about the ease of assessing corneal transplantation. After surgery, participants will be assessed on days 1, 7,15, 30, 60, 90 and 180 after surgery. Surgeries and study procedures will be performed by the same team of surgeons and performed by IPEPO - Paulista Institute of Studies and Research in Ophthalmology / Vision Institute.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2016

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2016

Completed
10 days until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 13, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

April 13, 2016

Status Verified

April 1, 2016

Enrollment Period

8 months

First QC Date

March 22, 2016

Last Update Submit

April 8, 2016

Conditions

Keywords

keratoconusbullous keratopathycorneal dystrophy

Outcome Measures

Primary Outcomes (1)

  • Assess optimal maneuvers in corneal transplantation (separation layers)

    assessed by a questionnaire responded by surgeons (no difficulty, some difficulty, very difficulty)

    Day 0

Secondary Outcomes (5)

  • Compare the time of surgery between groups

    Day 0

  • To describe the surgical difficulty for corneal transplantation

    Day 0

  • Change of Day 1 Ocular inflammation at 1 month (Day 30)

    from Day1 to Day30

  • Change from Baseline Intraocular Pressure at 6 months (Day180)

    from Baseline to Day 180

  • Change from Baseline Visual Acuity at 6 months (Day 180)

    from Baseline to Day 180

Study Arms (2)

Lumera Microscope with OCT RESCAN

EXPERIMENTAL

In the group microscope coupled to OCT, patients will undergo corneal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation

Procedure: Lumera Microscope with OCT RESCAN

Conventional Microscope

ACTIVE COMPARATOR

The control group will undergo corneal transplant with conventional microscope without coupled OCT. The team of surgeons will answer the questionnaire on the surgical difficulty regarding corneal transplantation

Procedure: Conventional Microscope

Interventions

corneal transplantation guided by Lumera Microscope with OCT RESCAN

Lumera Microscope with OCT RESCAN

corneal transplantation guided by Conventional Microscope

Conventional Microscope

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Visual acuity less than 20/60 in the affected eye
  • years at least
  • Diagnostic of the following diseases:
  • keratoconus
  • Keratopathy Bullosa
  • Corneal dystrophy

You may not qualify if:

  • Better visual acuity than or equal to 20/60

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Corneal DiseasesKeratoconusCorneal Dystrophies, Hereditary

Condition Hierarchy (Ancestors)

Eye DiseasesEye Diseases, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Walton Nose, MD, PhD

    Federal University of São Paulo UNIFESP

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ricardo Nose, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Ophthalmology

Study Record Dates

First Submitted

March 22, 2016

First Posted

April 13, 2016

Study Start

April 1, 2016

Primary Completion

December 1, 2016

Study Completion

March 1, 2017

Last Updated

April 13, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will share

scientific publication